Analysis of Meloxicam in accordance with the United States Pharmacopoeia (Assay)

LAAN-A-LC-E323 Application News No. High Performance Liquid Chromatography Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by NexeraTM XR L550 mAU 220 Meloxicam, inhibits the biosynthesis of prostaglandin, is utilized as an anti-inflammatory and analgesic for arthritis. In…

ERAS-1000-0149 LC Reversed-phase Shim-pack Series Shim-packTM GIST C18 Analysis of Meloxicam in accordance with the United States Pharmacopoeia 149 Keywords: Non-Steroidal Anti-Inflammatory Drug mAU 500 475 450 425 400 375 350 325 300 275 250 225 200 175 150 125…

C190-E256 Ultra High Performance Liquid Chromatograph Nexera series Technical Reports / Applications The Nexera Series: Reinvent Your Workflow Just as the internet and smartphones have changed our lifestyles, and robots with AI capabilities continue to make our lives more convenient,…

C190-E284 Technical Report Efficient method development based on Analytical Quality by Design with LabSolutions™ MD software Shinichi Fujisaki1, Satoru Watanabe1, Tomohiro Kawase1, Yuichiro Fujita1, Keiko Matsumoto1 A b s tra c t: This article describes the efficient development of robust…